Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Conjunctivitis - allergic - Drugs in this topic
Scenario: Seasonal or perennial allergic conjunctivitis

This level contains the following sections:

  • Antazoline 0.5% / Xylometazoline 0.05% eye drops
  • Azelastine 0.05% eye drops
  • Cetirizine 10mg tablets
  • Cetirizine 1mg/ml oral solution sugar free
  • Emedastine 0.05% eye drops
  • Fexofenadine 120mg tablets
  • Ketotifen 250micrograms/ml eye drops
  • Lodoxamide 0.1% eye drops
  • Loratadine 10mg tablets
  • Loratadine 5mg/5ml oral solution
  • Nedocromil 2% eye drops
  • Prednisolone 5mg gastro-resistant tablets
  • Prednisolone 5mg soluble tablets
  • Prednisolone 5mg tablets
  • Sodium cromoglicate 2% eye drops

© NHS Institute for Innovation and Improvement